Company
United StatesXeris Pharmaceuticals, Inc., Chicago, IL – FDA Inspections
Inspection records and compliance data for Xeris Pharmaceuticals, Inc. in Chicago, Illinois. 3 FDA inspections on record, last inspected July 03, 2025.
Company Profile
This profile covers Xeris Pharmaceuticals, Inc. based in Chicago, Illinois, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected March 14, 2019. Last inspected July 3, 2025.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 3, 2025 | NAI | Human Drugs · Bioresearch Monitoring | 1288372 |
| November 16, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1192023 |
| March 14, 2019 | NAI | Human Drugs · Bioresearch Monitoring | 1086592 |
FDA documents
Other FDA documents (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Xeris Pharmaceuticals, Inc.
FEI Number
3014193489
Address
180 N La Salle St Ste 1600, Chicago, Illinois 60601, United States
Country
United States
ID: 9cbcaba7-f788-4118-a53e-0134b660ffb5